The Oncology Institute Partners with House Rx to Accelerate Growth of Pharmacy Operations
31 Juillet 2023 - 2:00PM
The Oncology Institute (NASDAQ: TOI) and House Rx announced today
that they have entered into a multi-year relationship that will
integrate House Rx’s specialty medication dispensing model to
operate and manage TOI’s clinic and pharmacy locations in multiple
markets.
House Rx provides clinics with specialized
technology and services support from pharmacists and care
coordinators. House Rx staff are integrated with the
clinic to help patients start therapy as quickly as possible and
drive adherence to treatment for better outcomes.
TOI’s alignment with House Rx will expand patient access to oral
specialty medications via TOI dispensary and pharmacy locations,
and enhance in-office dispensary operations. The relationship will
further enable TOI to provide convenient and affordable access to
value-based therapies for patients as part of its comprehensive
community-based care model.
“By partnering with House Rx, we will accelerate the growth of
our clinic-based oral drug dispensing capabilities and improve our
ability to add pharmacy locations in California and Texas that will
allow us to access patient populations that we previously could not
serve,” said Dr. Daniel Virnich, CEO of The Oncology Institute. “We
see this as one of the key drivers of our growth in upcoming
years.”
"With TOI, we have an innovative partner that cares deeply about
delivering value-based care in the community setting," said Tesh
Khullar, President and Co-Founder of House Rx. "By adopting our
dispensing services and technology, TOI will strengthen their
value-based care offering by ensuring more patients can access
their specialty medications and receive the best possible outcomes
from their treatments.”
About The Oncology Institute, Inc.Founded in
2007, TOI is advancing oncology by delivering highly specialized,
value-based cancer care in the community setting. TOI offers
cutting-edge, evidence-based cancer care to a population of
approximately 1.8 million patients including clinical trials,
transfusions, and other care delivery models traditionally
associated with the most advanced care delivery organizations. With
100+ employed clinicians and more than 800 teammates in over 65
clinic locations and growing, TOI is changing oncology for the
better. For more information visit
www.theoncologyinstitute.com.
About House RxHouse Rx is a healthcare
technology and services company focused on making specialty
medication more accessible and affordable. The company partners
with specialty clinics across the country to enable community-based
clinics to offer medically integrated dispensing, ultimately
bringing together medical and pharmacy expertise to better serve
patients, lower the cost of care, and create a better experience
for patients and their caregivers. Learn more at
www.houserx.com.
Investors
Solebury Strategic Communications
investors@theoncologyinstitute.com
Oncology Institute (NASDAQ:TOI)
Graphique Historique de l'Action
De Jan 2025 à Fév 2025
Oncology Institute (NASDAQ:TOI)
Graphique Historique de l'Action
De Fév 2024 à Fév 2025